Deutscher Platz 5a
Leipzig 04103
Germany
49 341 48792 40
https://www.vita34.de
Sector(s):
Industry:
Full-time employees: 775
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Mr. Jakub Julian Baran | Chairman of the Management Board & CEO | N/A | N/A | N/A |
Mr. Tomasz Franciszek Baran | VP of the Management Board & Chief Commercial Officer | N/A | N/A | N/A |
Mr. Dirk Plaga | CFO & Member of Management Board | N/A | N/A | 1965 |
Santiago Luengo | Managing Director of Secuvita | N/A | N/A | N/A |
VITA 34 AG engages in the collection, processing, and storage of stem cells from umbilical cord blood and tissue in Germany, Spain, and internationally. It also develops cell therapeutic procedures; cell and gene therapies; cryopreservation of endogenous immune cells; and CAR-T. In addition, the company manufactures advanced therapy medicinal products based on mesenchymal stem cells for experimental treatment by specialized medical institutions; preserves stem cells from perinatal tissue and adult body fat; and engages in the contract manufacturing of pharmaceutical intermediates. VITA 34 AG was founded in 1997 and is based in Leipzig, Germany.
VITA 34 AG’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.